Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategy.
Gramling S; Rogers C; Liu G; Reisman D; Oncogene, 2011, vol. 30, issue 29, p 3289, ISSN 14765594. ISBN 14765594.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef